Aztiq Pharma Partners S.a r.l. → Alvotech ALVOW

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 15/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Short interest building (+60.6% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

1,309 shares short · +60.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $76K

Point72 Asset Mgmt

Other 13D/G Filings on Alvotech

Filed	Form	Filer	Stake	Shares
2026-06-30	SCHEDULE 13D/A	Celtic Holdings SCA	—	107,450,988	view →
2022-07-18	SC	Aztiq Pharma Partners S.a r.l.	—	—	view →
2022-07-15	SC	Celtic Holdings SCA	—	—	view →

Other Filings by Aztiq Pharma Partners S.a r.l.

Filed	Form	Issuer	Stake	Shares
2022-07-18	SC	Alvotech ALVOW	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →